![Molecules | Free Full-Text | Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer Molecules | Free Full-Text | Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer](https://www.mdpi.com/molecules/molecules-27-04578/article_deploy/html/images/molecules-27-04578-g001.png)
Molecules | Free Full-Text | Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer
![Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue | Clinical Proteomics | Full Text Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue | Clinical Proteomics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12014-015-9088-3/MediaObjects/12014_2015_9088_Fig1_HTML.gif)
Glycomic profiling of carcinoembryonic antigen isolated from human tumor tissue | Clinical Proteomics | Full Text
![Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf27a8f33dc1177ab0c7cf3c2adec21f5727b20d/3-Table1-1.png)
Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar
![Micromachines | Free Full-Text | Measurement of Carcinoembryonic Antigen in Clinical Serum Samples Using a Centrifugal Microfluidic Device Micromachines | Free Full-Text | Measurement of Carcinoembryonic Antigen in Clinical Serum Samples Using a Centrifugal Microfluidic Device](https://www.mdpi.com/micromachines/micromachines-09-00470/article_deploy/html/images/micromachines-09-00470-g001.png)
Micromachines | Free Full-Text | Measurement of Carcinoembryonic Antigen in Clinical Serum Samples Using a Centrifugal Microfluidic Device
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - The Breast Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - The Breast](https://www.thebreastonline.com/cms/asset/dcac75fc-f6de-4083-8493-14d9ad61eec6/fx1.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - The Breast
![Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases | Scientific Reports Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-70012-2/MediaObjects/41598_2020_70012_Fig1_HTML.jpg)
Bone marrow mammaglobin-1 (SCGB2A2) immunohistochemistry expression as a breast cancer specific marker for early detection of bone marrow micrometastases | Scientific Reports
![Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer](https://www.spandidos-publications.com/article_images/ol/20/1/ol-20-01-0742-g01.jpg)
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
Polydopamine nanosphere@silver nanoclusters for fluorescence detection of multiplex tumor markers - Nanoscale (RSC Publishing)
![Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-75319-8/MediaObjects/41598_2020_75319_Fig1_HTML.png)
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
![Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer | Scientific Reports Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep34131/MediaObjects/41598_2016_Article_BFsrep34131_Fig1_HTML.jpg)